Physician

Bachir Khalil Younes, M.D. , M.P.H.

According to 2025 Medicare claims, Bachir Younes, M.D. , M.P.H. (NPI: 1184661571) practices infectious disease in the Riverside-San Bernardino-Ontario, CA market, with the plurality of this provider's patient population coming from Riverside, CA. This provider's primary affiliated billing organization is YOUNES MEDICAL CORPORATION (NPI: 1881736312; TIN: 208413999) and primary practice location at 92211-6073. Younes is affiliated with the CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Younes' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 790 traditional Medicare patients, billed 395,448 HCPCS/CPT codes, and received $2,179,818 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 3,185 prescription claims across 409 beneficiaries totaling $4,761,936 in drug costs, led by Gammagard Liquid (Immun Glob G(Igg)/Gly/Iga Ov50). DME data shows 46 claims. Open Payments data shows 38 records totaling $1,251. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $1,392,999 to $2,179,818. Concurrently, Part D prescription costs have changed little. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $18,774 and ending at $5,615.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	713	267,699	$1,392,999
2016	718	356,972	$1,476,742
2017	631	38,669	$1,222,254
2018	662	53,995	$1,535,882
2019	622	77,694	$1,704,514
2020	615	90,331	$2,087,532
2021	583	80,693	$2,040,459
2022	734	102,165	$2,232,871
2023	719	35,920	$2,571,872
2024	790	395,448	$2,179,818

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	458	3,695	$4,192,876
2016	503	4,054	$4,595,419
2017	481	4,731	$5,019,528
2018	516	4,596	$5,318,758
2019	491	5,185	$5,537,823
2020	483	4,516	$5,665,839
2021	443	4,365	$5,486,063
2022	470	3,834	$5,542,849
2023	433	3,723	$5,900,331
2024	409	3,185	$4,761,936

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	12	155	$36,867
2016	N/R	162	$13,388
2017	11	127	$9,097
2018	N/R	90	$9,356
2019	N/R	162	$35,025
2020	13	244	$24,004
2021	35	132	$19,397
2022	N/R	60	$13,222
2023	N/R	47	$11,236
2024	N/R	46	$8,614

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	190	220	$134
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	539	1,701	$101
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	161	480	$94
97597	Removal of tissue from wound, 20.0 sq cm or less	145	2,065	$83
96365	Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less	361	8,736	$53

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Gammagard Liquid	Immun Glob G(Igg)/Gly/Iga Ov50	185	4,930	$1,236,828
Gammaked	Immune Globul G/Gly/Iga Avg 46	125	3,116	$818,570
Panzyga	Immun Glob G(Igg)-Ifas/Glycine	57	1,596	$473,513
Octagam	Immun Globg(Igg)/Malt/Iga Ov50	53	1,372	$437,756
Odefsey	Emtricitab/Rilpiviri/Tenof Ala	58	1,740	$215,736

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7682	Tobramycin, inhalation solution, fda-approved final product, non-compounded, unit dose form, administered through dme, per 300 milligrams	N	N/R	27	$8,122
Q0513	Pharmacy dispensing fee for inhalation drug(s); per 30 days	N	N/R	19	$492

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	38	$1,251	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Bachir Khalil Younes, M.D. , M.P.H.?

Tedicare shows public-source Medicare data for Bachir Khalil Younes, M.D. , M.P.H. (NPI 1184661571), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Bachir Khalil Younes, M.D. , M.P.H. have ACO affiliation data?

Bachir Khalil Younes, M.D. , M.P.H. is shown with ACO affiliation data for CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Bachir Khalil Younes, M.D. , M.P.H.?

Bachir Khalil Younes, M.D. , M.P.H. is linked to YOUNES MEDICAL CORPORATION (billing NPI 1881736312) in the available physician profile data.

Does Bachir Khalil Younes, M.D. , M.P.H. have Open Payments data?

Bachir Khalil Younes, M.D. , M.P.H. has 38 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.